(Hedgeweek) CVS Health Corp saw it stock price climb by 1.7% on Monday after news broke of planned a meeting between the healthcare giant and its major hedge fund investor, Glenview Capital Management, according to a report by MorningStar.
CVS shares up nearly 2% on news of Glenview meeting
This entry was posted in Syndicated. Bookmark the permalink.